LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Biotechnology?src=hash" target="_blank"gt;#Biotechnologylt;/agt;–The global eye allergy therapeutics market is expected to post a CAGR
close to 5% during the period 2019-2023, according to the latest market
research report by Technavio.
The global eye allergy therapeutics market is currently witnessing a
high patient pool seeking treatments for various types of eye allergies.
Allergic conjunctivitis is the most widely spread eye allergy type in
the spectrum of allergic diseases. In addition to the high prevalence
rate of eye allergies globally they are associated with patient
discomfort, morbidity, and decreased productivity, which accentuates
high demand for eye allergy therapeutics.
As per Technavio, the advent of a new drug class for the treatment of
eye allergies will have a positive impact on the market and contribute
to its growth significantly over the forecast period. This global
eye allergy therapeutics market 2019-2023 research report
also analyzes other significant trends and market drivers that will
affect market growth over 2019-2023.
Global eye allergy therapeutics market: Advent
of new drug class for the treatment of eye allergies
Although the traditional eye allergy therapeutics have proven clinical
benefits in reducing the signs and symptoms associated with eye
allergies. These drugs have potential side effects that can lead to
serious eye-related disorders. Most of these drugs have a similar
mechanism of action, i.e., targeting the H1 receptors to release
antibodies from the mast cell. However, with continuous investments in
research and development, market players have identified novel pathways
for the treatment of eye allergies. For instance, vendors have come out
with a novel, differentiated ophthalmic drop that is potent in providing
relief from the ocular itching associated with eye allergies. Similarly,
a few vendors were also engaged in conducting clinical trials for the
treatment of people with moderate-to-severe allergic conjunctivitis.
Therefore, such initiatives by vendors are expected to boost market
growth during the forecast period.
“The shift toward immunotherapy, the comorbidity associated with eye
allergies, the unmet need for minimal dose frequency drugs, and the
increasing pollution leading to various health hazards including eye
allergies are major aspects that will boost market growth for the coming
few years,” says a senior analyst at Technavio.
Global eye allergy therapeutics market:
Segmentation analysis
This market research report segments the global eye allergy therapeutics
market by product (antihistamines, mast cell stabilizers,
corticosteroids, immunomodulators, and others) and geographical regions
(North America, Europe, Asia, and ROW).
The North American region led the market in 2018, followed by Europe,
Asia, and ROW respectively. During the forecast period, the North
American region is expected to continue dominating as well as register
the highest incremental growth due to the increased investment in R&D by
large pharmaceutical companies and the presence of proper regulatory
framework for the approval of the new drugs in the region.
Looking for more information on this market? Request
a free sample report
Technavio’s sample reports are free of charge and contain multiple
sections of the report such as the market size and forecast, drivers,
challenges, trends, and more.
Some of the key topics covered in the report include:
Market Landscape
- Market ecosystem
- Market characteristics
- Market segmentation analysis
Market Sizing
- Market definition
- Market size and forecast
Five Forces Analysis
Market Segmentation
Geographical Segmentation
- Regional comparison
- Key leading countries
Market Drivers
Market Challenges
Market Trends
Vendor Landscape
- Vendors covered
- Vendor classification
- Market positioning of vendors
- Competitive scenario
About Technavio
Technavio
is a leading global technology research and advisory company. Their
research and analysis focuses on emerging market trends and provides
actionable insights to help businesses identify market opportunities and
develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists
of more than 10,000 reports and counting, covering 800 technologies,
spanning across 50 countries. Their client base consists of enterprises
of all sizes, including more than 100 Fortune 500 companies. This
growing client base relies on Technavio’s comprehensive coverage,
extensive research, and actionable market insights to identify
opportunities in existing and potential markets and assess their
competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team
at media@technavio.com.
Contacts
Technavio Research
Jesse Maida
Media & Marketing Executive
US:
+1 844 364 1100
UK: +44 203 893 3200
www.technavio.com